SCHEMBL20068

SCHEMBL20068

[C]1Nc2ccccc2O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5460351 1.00
SCHEMBL7172408 0.76 ALOX5 (0.39)
SCHEMBL10718730 0.69 AHR (0.41)
SCHEMBL4057389 0.69 KDM4E (0.43)
SCHEMBL154513 0.67 ALOX5 (0.39)
SCHEMBL18835 0.67 ALOX5 (0.39)
SCHEMBL11364 0.65 GAA (0.42)
SCHEMBL540480 0.65 ALOX5 (0.38)
SCHEMBL207167 0.65 ALOX5 (0.38)
SCHEMBL11404325 0.64 ALOX5 (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 6193 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118201911-A Compounds and their use as GPR183 inhibitors 南京艾美斐生物医药科技有限公司 2024-06-14 CN claimed
US-11713312-B2 Substituted bicyclic compounds as farnesoid X receptor modulators BRISTOL-MYERS SQUIBB COMPANY (US) 2023-08-01 US claimed
WO-2023064195-A1 CGRP ANTAGONISTS FOR TREATING TRIGEMINAL NEURALGIA PFIZER IRELAND PHARMACEUTICALS (IE) 2023-04-20 WO claimed
WO-2023034466-A1 CGRP ANTAGONISTS FOR TREATING PSORIASIS PFIZER IRELAND PHARMACEUTICALS (IE) 2023-03-09 WO claimed
WO-2023034467-A2 CGRP ANTAGONISTS FOR TREATING SKIN CONDITIONS PFIZER IRELAND PHARMACEUTICALS (IE) 2023-03-09 WO claimed
US-20220396571-A1 SPIROPIPERIDINE ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS MERCK SHARP & DOHME CORP. (US) 2022-12-15 US claimed
US-11352316-B2 Opioid receptor modulators and products and methods related thereto EPIODYNE, INC. (US) 2022-06-07 US claimed
US-20220135550-A1 SUBSTITUTED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS BRISTOL MYERS SQUIBB CO (US) 2022-05-05 US claimed
EP-3924336-A1 SUBSTITUTED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS Bristol-Myers Squibb Company (US) 2021-12-22 EP claimed
US-20210163402-A1 OPIOID RECEPTOR MODULATORS AND PRODUCTS AND METHODS RELATED THERETO EPIODYNE, INC. 2021-06-03 US claimed
EP-0068877-B1 TELLUROPYRYLIUM COMPOUNDS AND ELECTRON DONATING PHOTOCONDUCTIVE COMPOSITIONS CONTAINING SAME EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1987-07-29 EP claimed
US-4628061-A Prostaglandins NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1986-12-09 US claimed
US-4596823-A Prostaglandins NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1986-06-24 US claimed
US-4584258-A INFRARED ABSORBING DYE-CONTAINING COATING FOR OPTICAL RECORDING MEDIA EASTMAN KODAK COMPANY (US) 1986-04-22 US claimed
US-4576905-A Photographically useful chalcogenazoles, chalcogenazolines, and chalcogenazolinium and chalcogenazolium salts EASTMAN KODAK COMPANY (US) 1986-03-18 US claimed
US-4575483-A FACILITATE IMAGE FORMATION EASTMAN KODAK COMPANY (US) 1986-03-11 US claimed
EP-0138362-A2 Photographic materials containing chalcogenazoles, chalcogenazolines and chalcogenazolinium and chalcogenazolium salts EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1985-04-24 EP claimed
EP-0136847-A2 Photographically useful chalcogenazolylidene and chalcogenazolium dyes and methods for their preparation EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1985-04-10 EP claimed
EP-0068877-A2 Telluropyrylium compounds and electron donating photoconductive compositions containing same EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1983-01-05 EP claimed
US-4365017-A ELECTROGRAPHY EASTMAN KODAK COMPANY (US) 1982-12-21 US claimed